Search

Your search keyword '"Deryck, Olivier"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Deryck, Olivier" Remove constraint Author: "Deryck, Olivier" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
42 results on '"Deryck, Olivier"'

Search Results

1. Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study.

3. Clinical variability and onset age modifiers in an extended Belgian GRN founder family

4. A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis

5. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum

6. Microtubule associated protein tau p.R406W patient carriers present with a nonconforming clinical phenotype

7. Alzheimer’s disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical Association

8. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum

10. Frequent MAPT p.R406W Carriers with a Nonconforming FTD Phenotype in the Belgian Population (S20.006)

11. Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort

12. NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

13. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

14. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

15. Diagnostic performance of automated MRI volumetry by icobrain DM for Alzheimer's disease in a clinical setting: A REMEMBER study

16. Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study

17. Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.

18. Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability

19. Dementia, End of Life, and Euthanasia: A Survey Among Dementia Specialists Organized by the Belgian Dementia Council.

20. Dementia, End of Life, and Euthanasia: A Survey Among Dementia Specialists Organized by the Belgian Dementia Council

21. A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).

22. A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.

23. A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).

24. A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis

25. No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients

26. Clinical variability and onset age modifiers in an extended Belgian GRN founder family

27. A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer’s Disease (REMEMBER)

28. Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort

29. NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

30. TBK1Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

31. Clinical Evidence of Disease Anticipation in Families Segregating aC9orf72Repeat Expansion

32. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

34. Clinical evidence for genetic anticipation in C9orf72 pedigrees

35. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter

36. Clinical Evidence for Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion (S21.006)

37. Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer's disease: a BeDeCo survey.

38. Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer’s disease: a BeDeCo survey

39. No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients

40. Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion.

41. Ofatumumab versus Teriflunomide in Multiple Sclerosis

42. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.

Catalog

Books, media, physical & digital resources